Approval from FDA to initiate Phase II trial with LSALT peptide to target cardiac surgery-associated acute kidney injury (CS-AKI) LSALT peptide targets dipeptidase-1 (DPEP-1), an enzyme known to ...
Arch Biopartners (ACHFF) announced that the University Health Network Research Ethics Board has granted ethics approval for St. Michael’s Hospital, a site of Unity Health Toronto, to participate in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results